Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Novel anticancer TLR7 agonists disclosed

June 14, 2012

Jenrin Discovery designs novel compounds targeting the cannabinoid CB1 receptor

June 14, 2012

Novel agents for migraine prepared at Merck & Co.

June 14, 2012

Synta Pharmaceuticals prepares new IL-2/CRAC-targeted products

June 13, 2012

New PI3K inhibitors developed in U.S.

June 13, 2012

Merck & Co. reports new CGRP receptor antagonists

June 13, 2012

Novel diagnostics disclosed by Janssen Pharmaceuticals

June 13, 2012

Bristol-Myers Squibb patents novel inhibitors of CYP17

June 13, 2012

Roche presents novel LRRK2 inhibitors

June 13, 2012

New ENTPD5 inhibitors developed by University of Texas System

June 12, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...